Trial intelligence / Profile preview

Lot Consistency Trial of Freeze-Dried MVA-BN Smallpox Vaccine

NCT03699124Phase 3Completed

Sponsor
Bavarian Nordic
Start
Jun 2019
Primary completion
Jan 2020
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 3 trial of JYNNEOS in smallpox, mpox, sponsored by Bavarian Nordic. Started Jun 2019; status: completed.

02

Drugs

JYNNEOS
03

Conditions

smallpoxmpox

Beyond the preview

Go deeper on NCT03699124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03699124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call